Analysis of conjunctival fibroblasts from a proband with Schnyder corneal dystrophy by Mehta, Jodhbir S. et al.
Analysis of conjunctival fibroblasts from a proband with Schnyder
corneal dystrophy
Jodhbir S. Mehta,1,2 Eranga N. Vithana,1,3 Divya Venkataraman,1 Anandalakshmi Venkatraman,1 Rebekah Poh,
1 Roger W. Beuerman,1,3 Tin Aung,1,2,3 Donald T.H. Tan1,2,3
1Singapore Eye Research Institute, Singapore; 2Singapore National Eye Centre, Singapore; 3Department of Ophthalmology, Yong
Loo Lin School of Medicine, National University of Singapore, Singapore
Purpose: To analyze for the presence of lipids in conjunctival fibroblasts of a patient with Schnyder corneal dystrophy
(SCD).
Methods: A proband with SCD was identified, and the pedigree was examined. The proband underwent an automated
lamellar therapeutic keratoplasty (ALTK). At the same time, the proband underwent a skin and conjunctival biopsy.
Specimens were sent for histological and ultrastructural examination. Conjunctival fibroblasts were cultured from the
biopsy specimen and stained with filipin.
Results: The proband showed no evidence of recurrence following the ALTK procedure. Histopathological examination
showed no evidence of hydrophobic lipids in the conjunctival or dermal fibroblasts. Lipid particles were detected in the
cornea. Ultrastructural examination showed no lipid particles in the conjunctival fibroblasts. Cultured fibroblasts showed
no evidence of intracellular unesterified cholesterol unless low density lipoprotein (LDL) was added to the culture medium.
Conclusions: There was no evidence of lipid deposition in conjunctival or skin fibroblasts in our patient with SCD. The
evidence suggests local factors are responsible for the lipid deposition in the cornea.
Schnyder corneal dystrophy (SCD; OMIM 121800) is a
rare  autosomal  dominant  inherited  condition  [1]  that  is
characterized by bilateral anterior stromal haze or crystalline
deposits in early life. Later, patients develop increasingly
dense corneal arcus and diffuse stromal haze [1-8]. Crystalline
deposition is not a prerequisite to diagnosing this condition,
and 49% of patients have no evidence of crystalline deposits
upon clinical examination [9]. The phenotypic presentation is
caused  by  the  abnormal  deposition  of  cholesterol  and
phospholipids  in  the  cornea  [10].  Systemic
hypercholesterolemia is associated with up to 66% of patients
with  SCD  [11].  However,  these  abnormalities  may  occur
without the presence of corneal abnormalities in pedigrees of
SCD [12,13], suggesting an independent trait. Hence, it was
hypothesized that local factors may affect lipid/cholesterol
transport  leading  to  deposition  in  the  cornea.  This  was
supported by the observations that early crystal deposition is
often in the center of the cornea, implicating a temperature
dependant enzyme defect [14,15] and that the cornea can
actively uptake radioactive cholesterol [15].
In  1998,  Battisti  et  al.  [16]  showed  the  presence  of
abnormal lipid storage in skin and cultured dermal fibroblasts
from a pedigree with SCD. All the patients had normal serum
lipid  analysis.  They  concluded  that  the  lipid  storage
abnormality was not limited to the cornea and that skin biopsy
may be used to confirm the diagnosis. The aim of this study
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was to report on the analysis of conjunctival fibroblasts from
a patient with SCD to examine for the presence of cholesterol
accumulation.
METHODS
The  protocol  of  the  study  adhered  to  the  tenets  of  the
Declaration of Helsinki and was approved by the institutional
review board and ethics committees of the Singapore National
Eye Centre and Singapore Eye Research Institute.
The proband and her family were evaluated clinically at
the  Singapore  National  Eye  Centre  by  slit  lamp
biomicroscopy. Available clinical records, family history, and
photographs were reviewed. Informed consent was obtained
and the proband underwent an automated lamellar therapeutic
keratoplasty (ALTK). A histopathologic study was performed
on the excised corneal button and conjunctival (from two
areas)  and  skin  biopsies  were  taken  during  the  same
procedure.
All members of the family of the pedigree underwent a
complete  ophthalmic  examination.  This  included  manifest
refraction,  visual  acuity,  contrast  sensitivity  with  glare,
corneal  sensation,  applanation  tonometry,  pupil  reactions,
motility, visual fields, corneal pachymetry, dilated fundus
examination, and knee examination. Slit lamp examination
and  slit  lamp  photography  was  performed  to  assess  and
document the crystalline deposits and the degree of stromal
haze and arcus lipoides to determine the disease status for each
family  member.  Anterior  segment  optical  coherence
tomography (ASOCT, Carl Zeiss Meditec, Jena, Germany)
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1277was performed to assess depth of the lesions (Figure 1). All
patients also underwent fasting serum blood cholesterol and
triglyceride levels.
Histopathology: The tissue specimens (conjunctiva, skin,
and  cornea)  were  paraffin  sectioned  and  stained  with
hematoxylin  and  eosin  and  oil  Red-O  to  detect  for
hydrophobic  lipids  (cholesteryl  ester  and  triglyceride)  by
standard techniques.
Cell culture: The conjunctival tissue was cut into 0.5 mm
to 1 mm pieces and cultivated as explants on a sterile Petri
dish with 500 µl of Dulbecco’s modified Eagle’s medium
(Invitrogen, Carlsbad, CA) with nutrient mix F12 (DMEM
Nut F12; Sigma Aldrich, St. Louis, MO) supplemented with
2 ng/ml human epidermal growth factor (Sigma Aldrich), 1
µg/ml  bovine  insulin  (Sigma  Aldrich),  0.5  µg/ml
hydrocortisone (Sigma Aldrich), 10% heat-inactivated fetal
bovine  serum  (Invitrogen),  penicillin  (5,000  units/ml),
streptomycin (5,000 µg/ml; Sigma Aldrich), and fungizone
(2.5 µg/ml; Sigma Aldrich). When cellular outgrowth from
the explants was observed, the volume of the medium was
increased  to  fully  immerse  the  explants.  The  cells  were
incubated at 37 °C under 5% CO2/95% air with the medium
changed every two to three days. Cultures were monitored
under an inverted phase-contrast microscope (Axiovert; Carl
Zeiss Meditec, Oberkochen, Germany). When a confluent
layer of cells was obtained on the dish after 8–10 days, the
cells were passaged. This was performed by detaching the
cells with trypsin-EDTA (0.25%-1 mM; Invitrogen) for 2 min
and  then  by  seeding  them  on  a  six  well  plate  containing
DMEM  Nutrient  F12  medium  supplemented  as  above.
Following  one  passage,  the  cells  were  grown  again  to
confluence in a six well plate. In half the six well plates, 5%
low density lipoprotein (LDL; Sigma Aldrich) was added to
act as a positive control. We then examined for non-esterified
Figure 1. Color slit lamp photomicrographs of the proband IV:4. A:
The image shows the proband’s left eye (OS) before ALTK. B: The
image shows the same eye five years following ALTK with no signs
of recurrence. C: Pre Pre-operative ASOCT of the proband showing
hyper-reflective signal, indicating the depth of the crystalline lesions.
cholesterol using filipin stain (25µg/ml; a polyene antibiotic
that selectively binds to the 3-beta-hydroxy-sterols; Sigma
Aldrich) with a previously described method [17]. The filipin
dye was excited with epi-illumination using ultraviolet light
(Axioplan,  Zeiss  Light  Microscope,  Carl  Zeiss),  and
fluorescence was viewed through a 510 nm barrier filter.
Electron  microscopy:  The  conjunctival  tissue  was
removed  and  immediately  fixed  with  cold  2%
paraformaldehyde and 2% glutaraldehyde in 0.1 M sodium
cacodylate buffer, pH 7.4 (Electron Microscopy Sciences,
Hatfield, PA) at 4 °C overnight. The tissue was then washed
in sodium cacodylate buffer and rinsed with distilled water.
The  tissue  was  then  trimmed  into  smaller  pieces.  These
samples  were  then  post-fixed  in  1%  osmium  tetroxide
(Electron Microscopy Sciences). After extensive rinsing with
distilled water, tissues were dehydrated in a graded series of
ethanol  and  embedded  in  araldite  (Electron  Microscopy
Sciences). All semi-thin sections (0.5–1 µm thick) were cut
with Reichert-Jung Ultracut E Ultramicrotome (C. Reichert
Optische Werke AG, Vienna, Austria), counter-stained with
toluidine blue/basic fuchsin stain, and examined using a Zeiss
Axioplan  Light  Microscope  (Carl  Zeiss).  All  ultra-thin
sections of 60–80 nm were collected on copper grids, doubled-
stained with uranyl acetate and lead citrate for 8 min each, and
then  viewed  and  photographed  on  a  JEM  1220  electron
microscope (JEOL, Tokyo, Japan) at 100 kV.
RESULTS
Clinical findings: The proband (IV:4, Figure 2) was a 30-year-
old Chinese woman who complained of increasing glare in
both eyes. Uncorrected visual acuity (UCVA) was 20/80 OD
and 20/80 OS. Best spectacle corrected vision (BSCVA) was
20/30 OD (−3.25/-1x165) and 20/ 30 OS (−3/-0.5x165). Pelli-
Robson contrast sensitivity was OD 1.2, OS 1.5 with glare,
OD 0.45, OS 0.6. Slit lamp examination of both eyes showed
central axial subepithelial cholesterol crystals (Figure 1A)
with arcus lipoides. There was no corneal vascularization or
active inflammation. There was no stromal haze. Corneal
sensation was normal in both eyes. She did not have genu
valgum.  Blood  cholesterol  was  within  normal  limits.  The
depth of her lesions on ASOCT was 220 microns, and the
central corneal thickness was 540 microns. She underwent a
two  stage  automated  lamellar  therapeutic  keratoplasty
(ALTK; Moria, Antony, France) using a previously described
technique [18]. Five years after the operation, the BSCVA was
20/20  (−0.75/-2.50x175)  with  no  evidence  of  the  crystals
recurring (Figure 1B). Details of mutations in the UBIAD1
gene in this pedigree (S171P) and clinical features of other
members of this family have been previously described [19].
She is awaiting surgery on the other eye.
Histopathology: Histopathologic evaluation of the excised
corneal  button  revealed  disruption  and  replacement  of
Bowman’s  layer  by  connective  tissue.  There  were  fine
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1278spherical lipid particles deposited in the anterior part of the
section to a level of 200 microns depth. Oil Red-O stained
these particles, and there was also diffuse staining of the
extracellular connective tissue matrix. Examination of the
conjunctival and skin biopsy did not show the presence of
triglyceride  in  the  conjunctival  fibroblasts  or  esterified
cholesterol in the dermal fibroblasts as examined by oil Red-
O staining (Figure 3A-D).
Ultrastructural  study  of  fibroblasts–electron  microscopy:
Ultra-structural examination of the conjunctival biopsy did
not  show  the  presence  of  electron-lucent  vacuoles  in  the
fibroblast cytoplasm signifying lipid vacuoles (Figure 4).
Cytochemical  staining  of  unesterified  cholesterol:
Fluorescence microscope examination of the filipin-stained
conjunctival fibroblasts from the wells without LDL did not
show the presence of unesterified cholesterol in the cytoplasm
Figure 2. Pedigree of our Chinese family with Schnyder corneal
dystrophy.  The  proband  is  IV:4.  Eleven  of  the  pedigree  were
examined, eight out of the nine affected members and three of the
unaffected members. The sharp (hash mark) indicates that these
members have hyperlipoproteinemia.
Figure 3. Histological sections of conjunctival and skin biopsy, from
the proband. A: Hematoxylin and Eosin staining of conjunctival
fibroblasts  (40X).  B:  Negative  result  of  oil  Red-O  staining  of
conjunctival fibroblasts (400X). C: Hematoxylin and Eosin staining
of  skin  biopsy  (40X).  D:  Negative  result  of  oil  Red-O  staining
of dermal fibroblasts (400X). E: Positive control for oil Red-O stain;
lid margin staining the meiobium gland (100X). F: Negative control
for oil Red-O stain; Normal cornea (100X).
(Figure 5C). The cells that had the addition of LDL showed
cytoplasmic deposits of fluorescent inclusions throughout the
cytoplasm especially in the perinuclear area (Figure 5D).
DISCUSSION
Schnyder corneal dystrophy is rare. The majority of reported
cases have been from pedigrees of European ancestry [20].
More recently families from African American, Japan, and
Turkish ethnicities have been described [21]. There are few
reports in Chinese patients [22]. Recently, the gene for SCD
has been identified [21,23], and the report by Battisti et al.
[16] implies that the UBIAD1 gene may play a role in lipid
metabolism throughout the body. The authors showed the
Figure 4. Transmission electron microscopy of conjunctival biopsy
from  the  proband.  A:  Low  power  (2000X)  section  showing
conjunctival epithelium (red star), goblet cell (white arrow) and
conjunctival fibroblast (red arrow). B: High power section (5000X)
of stromal fibroblastic tissue showing an absence of lipids in the
cytoplasm of the conjunctival fibroblast.
Figure 5. Fibroblast cell culture from the conjunctival biopsy of the
proband. A: Fibroblastic cellular outgrowth from the conjunctival
biopsy  tissue.  B:  Following  one  week  of  cell  culture,  cellular
confluence of fibroblasts is achieved. C: Following the addition of
filipin  stain,  there  is  no  evidence  of  cholesterol  in  the  cultured
conjunctival fibroblasts. D: Cells cultured with the addition of low
density  lipoprotein  (LDL),  acted  as  a  positive  control  showing
evidence of cholesterol with filipin staining. (Bar=100 microns).
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1279presence of lipid material in the skin fibroblasts from patients
with SCD. Interestingly, all the patients had normal serum
cholesterol levels, implying that perhaps the same local effect
occurring  in  the  eye  may  also  be  found  in  the  skin.  We
hypothesized  that  if  there  was  lipid  deposition  in  dermal
fibroblasts, then fibroblastic cells in other tissues may show
lipid  deposition.  However,  we  were  unable  to  show  lipid
deposition in our patient’s conjunctiva fibroblasts, and we
could not verify the previously reported finding of lipids in
the skin biopsy in SCD patients [16].
In the pedigree reported by Battisti et al. [16], two of the
three examined patients had evidence of genu valgum. None
of the members of our pedigree had this clinical sign. In a
study of over 115 patients with SCD, this clinical sign was
only documented in five [21]. The association between these
two conditions is unclear. Some authors postulate an alteration
in a pleiotropic gene, with variable penetrance [5]. Others
suggest they are inherited as independent traits [24]. It may
be that patients with genu valgum and SCD represent a more
widespread syndromic disorder.
The identification of UBIAD1 as the causative gene in
SCD has shed more insight in the underlying pathogenesis of
this  condition.  UBIAD1  (previously  know  as  TERE  1
[transitional epithelia response protein 1] or RP4–796F18) is
widely know to be expressed throughout human tissues [25].
UBIAD1 interacts with the COOH-terminal portion of apo E
[26], which is known to be involved in cholesterol transport,
especially in mediating solubilization and in the removal of
cholesterol from cells [27]. Hence, an obvious association
between a defect in UBIAD1 and cholesterol transportation is
present [28,29]. However, UBIAD1 also contains a prenyl-
transferase  domain,  which  is  involved  in  cholesterol
synthesis. Therefore, a defect in UBIAD1 may be associated
with  an  increase  in  local  cholesterol  synthesis  [28].  The
inability to detect lipid deposition in our dermal fibroblasts
may be due to different mutations between our family and that
described by Battisti et al. [16]. Although no correlation has
been  found  between  UBIAD1  mutations  and  ocular
phenotypes  [21],  there  may  be  a  genotype-phenotype
correlation with extra-ocular deposition of lipids.
In summary, we were unable to identify the deposition of
lipid in the skin and conjunctival fibroblasts of our proband
with SCD. Larger samples are needed to verify our initial
observations  documented  here,  but  the  results  suggest  a
localized abnormality in cholesterol metabolism in the cornea.
The  identification  of  UBIAD1  offers  new  interest  in
understanding  the  underlying  pathogenetic  mechanism
involved  in  this  condition.  Investigation  into  the  tissue-
specific  expression  of  UBIAD1  and  research  into  the
functional analysis of the effects of different mutations on the
conformational changes in the protein may elucidate some of
these questions.
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